SPR206 (acetate)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


SPR206 (acetate)
Description:
SPR206 acetate is a polymyxin analog with antibiotic activity against Gram-negative pathogens, including multidrug-resistant (MDR) variants. SPR206 acetate has an anti-bacterial infection effect by interacting with the bacterium’s outer membrane. The MIC values of SPR206 acetate against Pseudomonas aeruginosa Pa14 and Acinetobacter baumannii NCTC13301 are both 0.125 mg/L[1][2].UNSPSC:
12352005Target:
Antibiotic; BacterialType:
Reference compoundRelated Pathways:
Anti-infectionApplications:
COVID-19-immunoregulationField of Research:
InfectionAssay Protocol:
https://www.medchemexpress.com/spr206-acetate.htmlPurity:
98.88Solubility:
DMSO : ≥ 100 mg/mLSmiles:
O=C(N[C@@H](CC(C)C)C(N[C@@H](CCN)C(N[C@@H](CCN)C(N1)=O)=O)=O)[C@H](NC([C@H](CCN)NC([C@H](CCNC([C@@H]1[C@H](O)C)=O)NC([C@H](CN)NC([C@@H](NC(C[C@@H](C2=CC=CC(Cl)=C2)CN)=O)[C@H](O)C)=O)=O)=O)=O)CC3=CC=CC=C3.CC(O)=O.[x]Molecular Formula:
C52H82ClN15O12.xC2H4O2References & Citations:
[1]Brown P, et al. Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206. ACS Infect Dis. 2019 Oct 11;5 (10) :1645-1656.|[2]L. Grosser, et al. In Vivo Efficacy of SPR206 in Murine Lung and Thigh Infection Models Caused by Multidrug Resistant Pathogens Pseudomonas aeruginosa and Acinetobacter baumanii. Poster-139 ASM ESCMID 2018 Lisbon, Portugal.|[3]Noushin Akhoundsadegh, et al. Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli. Antimicrob Agents Chemother. 2019 Sep 23;63 (10) :e00935-19.Shipping Conditions:
Blue IceStorage Conditions:
-20°C (Powder, sealed storage, away from moisture)Scientific Category:
Reference compound1Clinical Information:
Phase 1CAS Number:
[2408422-41-1]
